DAK Gesundheit Tender

Contract notice: Conclusion of a non-exclusive discount agreement according to § 130a abs. 8 sgb v on the active ingredient diazepam, Atc n05ba01, For the period 1.10.2019 - 30.9.2021 dak-gesundheit ( dak-g ) assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory access of all pharmaceutical companies. Irrespective of this, It automatically ends with the entry into force of the exclusive contract for diazepam, Atc n05ba01, As a result of a formal award procedure in accordance with the regulations of part 4 of the gwb with one or more contractual partners. In order to cope with the diversity of potential contractors under the authorization model, Each pharmaceutical company will be able to conclude a framework contract at any time and under the same conditions during the contract period. The contract documents required for this purpose are available for download via the online portal www.dtvp.de/center under the link under i.3). Prerequisites for the conclusion or subsequent accession to the contracts that come into effect on october 1, 2019 are the complete and timely submission of the following evidence / explanations / attachments (available for download under the link under i.3.) to the following listed contact person at the dak-g: 1) offer letter; 2) current proof of entry in the professional or commercial register (see iii.1.1.); 3) self-declaration by the company (annex a1) that none of the exclusion criteria pursuant to sections 123, 124 gwb exist (see iii.1.1.); 4) self-declaration that for those medicinal products for which the prospective buyer wishes to conclude a contract under this procedure, There is a drug license and that the bidder is entitled to distribution at the inception of the contract (appendix a2) (see iii.1.1.); 5) self-declaration by the company that the statutory minimum wage and tariff compliance requirements are observed and complied with (annex a3) (see iii.1.1.); 6) acknowledgment of the contractual stipulations of the dak-g, In particular also the prescribed discounts by signing the contract stamped with a company stamp (twice in the original) by the interested party at the designated place; 7) appendices 1 and 2 to the contract (twice each in the original). The interested party has here to enter the medicines for the above-mentioned active substance, Which should become the subject of the contract; 8) effective prequalification notice of dak-g (see iii.1.1 and iii.1.2.). The documents must be submitted by post to: Dak health henri affinass (0032 50) nagelsweg 27-31 20097 hamburg furthermore, The attachment 2 is sent as an excel file at the same time to the mail address am_rabattvertraege@dak.de . Contracts under this model and the aforementioned active substance will be concluded for the first time with effect from 1.10.